• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞调控移植物抗宿主病:免疫刺激与耐受。

Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance.

机构信息

Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA, United States.

Department of Medicine, Pennsylvania State University, Hershey, PA, United States.

出版信息

Front Immunol. 2019 Feb 1;10:93. doi: 10.3389/fimmu.2019.00093. eCollection 2019.

DOI:10.3389/fimmu.2019.00093
PMID:30774630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6367268/
Abstract

Graft-vs.-host disease (GVHD) remains a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Significant progresses have been made in defining the dichotomous role of dendritic cells (DCs) in the development of GVHD. Host-derived DCs are important to elicit allogeneic T cell responses, whereas certain donor-types of DCs derived from newly engrafted hematopoietic stem/progenitor cells (HSPCs) can amply this graft-vs.-host reaction. In contrast, some DCs also play non-redundant roles in mediating immune tolerance. They induce apoptotic deletion of host-reactive donor T cells while promoting expansion and function of regulatory T cells (Treg). Unfortunately, this tolerogenic effect of DCs is impaired during GVHD. Severe GVHD in patients subject to allo-HSCT is associated with significantly decreased number of circulating peripheral blood DCs during engraftment. Existing studies reveal that GVHD causes delayed reconstitution of donor DCs from engrafted HSPCs, impairs the antigen presentation function of newly generated DCs and reduces the capacity of DCs to regulate Treg. The present review will discuss the importance of DCs in alloimmunity and the mechanism underlying DC reconstitution after allo-HSCT.

摘要

移植物抗宿主病(GVHD)仍然是异基因造血干细胞移植(allo-HSCT)后发病率和死亡率的重要原因。在确定树突状细胞(DCs)在 GVHD 发展中的双重作用方面已经取得了重大进展。宿主来源的 DCs 对于引发同种异体 T 细胞反应很重要,而来自新植入造血干细胞/祖细胞(HSPCs)的某些供体类型的 DCs 可以充分放大这种移植物抗宿主反应。相比之下,某些 DCs 也在介导免疫耐受方面发挥非冗余作用。它们诱导宿主反应性供体 T 细胞的凋亡性删除,同时促进调节性 T 细胞(Treg)的扩增和功能。不幸的是,DCs 的这种耐受作用在 GVHD 期间受损。接受 allo-HSCT 的患者发生严重 GVHD 与植入期间外周血循环 DC 数量明显减少有关。现有研究表明,GVHD 导致来自植入 HSPC 的供体 DC 重建延迟,损害新生成的 DC 的抗原呈递功能,并降低 DC 调节 Treg 的能力。本综述将讨论 DCs 在同种免疫中的重要性以及 allo-HSCT 后 DC 重建的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fba6/6367268/2576c6588bb4/fimmu-10-00093-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fba6/6367268/590125fdab1c/fimmu-10-00093-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fba6/6367268/2576c6588bb4/fimmu-10-00093-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fba6/6367268/590125fdab1c/fimmu-10-00093-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fba6/6367268/2576c6588bb4/fimmu-10-00093-g0002.jpg

相似文献

1
Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance.树突状细胞调控移植物抗宿主病:免疫刺激与耐受。
Front Immunol. 2019 Feb 1;10:93. doi: 10.3389/fimmu.2019.00093. eCollection 2019.
2
Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.供体树突状细胞诱导的受体来源的同种异体诱导性调节性T细胞有效抑制供体T细胞增殖并减轻移植物抗宿主病。
Anat Rec (Hoboken). 2019 May;302(5):825-836. doi: 10.1002/ar.23972. Epub 2018 Nov 25.
3
Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice.Delta-like 配体 4 鉴定了一种以前尚未表征的炎症性树突状细胞群体,该群体在诱导小鼠同种异体 T 细胞反应中发挥重要作用。
J Immunol. 2013 Apr 1;190(7):3772-82. doi: 10.4049/jimmunol.1202820. Epub 2013 Feb 25.
4
Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution.Campath-1G在同种异体移植前会导致循环中的宿主树突状细胞(DCs)迅速耗竭,但不会延迟供体DC的重建。
Blood. 2002 Apr 1;99(7):2586-91. doi: 10.1182/blood.v99.7.2586.
5
Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.树突状细胞与移植物抗宿主病和移植物抗白血病活性的调节。
Blood. 2012 May 31;119(22):5088-103. doi: 10.1182/blood-2011-11-364091. Epub 2012 Mar 7.
6
Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.利用同种异体δ样配体4阳性树突状细胞对供体T细胞进行编程以减少小鼠移植物抗宿主病
Blood. 2016 Jun 23;127(25):3270-80. doi: 10.1182/blood-2015-05-644476. Epub 2016 May 3.
7
Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.造血干细胞移植操作作为一种免疫治疗机制。
Int Immunopharmacol. 2003 Aug;3(8):1121-43. doi: 10.1016/S1567-5769(03)00014-6.
8
Tolerance induction between two different strains of parental mice prevents graft-versus-host disease in haploidentical hematopoietic stem cell transplantation to F1 mice.在半相合造血干细胞移植到 F1 小鼠中,诱导来自两个不同亲鼠品系的耐受可预防移植物抗宿主病。
Biochem Biophys Res Commun. 2014 Apr 18;446(4):1035-41. doi: 10.1016/j.bbrc.2014.03.055. Epub 2014 Mar 21.
9
Role of glucocorticoid-induced leucine zipper (GILZ) expression by dendritic cells in tolerance induction.树突状细胞诱导糖皮质激素诱导亮氨酸拉链(GILZ)表达在诱导耐受性中的作用。
Transplant Proc. 2010 Oct;42(8):3331-2. doi: 10.1016/j.transproceed.2010.07.038.
10
Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation.异基因清髓性造血干细胞移植后浆细胞样和髓样树突状细胞前体的重建动力学
Blood. 2004 Jul 1;104(1):281-9. doi: 10.1182/blood-2003-07-2443. Epub 2004 Mar 9.

引用本文的文献

1
Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.移植物抗宿主病小鼠模型:临床转化视角
Methods Mol Biol. 2025;2907:1-56. doi: 10.1007/978-1-0716-4430-0_1.
2
Implanting mechanically reprogrammed fibroblasts for aged tissue regeneration and wound healing.将机械重编程成纤维细胞植入老化组织再生和伤口愈合。
Aging Cell. 2024 Feb;23(2):e14032. doi: 10.1111/acel.14032. Epub 2023 Nov 27.
3
Immunological dynamic characteristics in acute myeloid leukemia predict the long-term outcomes and graft-versus host-disease occurrences post-transplantation.

本文引用的文献

1
Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation Outcomes.Flt3L 治疗骨髓供者可增加移植物浆细胞样树突状细胞含量并改善同种异体移植结局。
Biol Blood Marrow Transplant. 2019 Jun;25(6):1075-1084. doi: 10.1016/j.bbmt.2018.11.029. Epub 2018 Nov 29.
2
Regulatory dendritic cells: profiling, targeting, and therapeutic application.调节性树突状细胞:特征分析、靶向作用及治疗应用
Curr Opin Organ Transplant. 2018 Oct;23(5):538-545. doi: 10.1097/MOT.0000000000000565.
3
Flt-3L Expansion of Recipient CD8α Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHD.
急性髓系白血病中的免疫动力学特征可预测移植后长期结局和移植物抗宿主病的发生。
Clin Exp Immunol. 2024 Feb 7;215(2):148-159. doi: 10.1093/cei/uxad123.
4
Tolerogenic dendritic cells and TLR4/IRAK4/NF-κB signaling pathway in allergic rhinitis.变应性鼻炎中的耐受树突状细胞和 TLR4/IRAK4/NF-κB 信号通路。
Front Immunol. 2023 Oct 17;14:1276512. doi: 10.3389/fimmu.2023.1276512. eCollection 2023.
5
Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease Exhibits Activation of T Helper 1 and OX40 Cytokines.硬化型皮肤慢性移植物抗宿主病表现出辅助性 T 细胞 1 和 OX40 细胞因子的激活。
J Invest Dermatol. 2024 Mar;144(3):563-572.e9. doi: 10.1016/j.jid.2023.08.026. Epub 2023 Sep 23.
6
After Bone Marrow Transplantation, the Cell-Intrinsic Th2 Pathway Promotes Recipient T Lymphocyte Survival and Regulates Graft-versus-Host Disease.骨髓移植后,细胞内源性 Th2 途径促进受者 T 淋巴细胞存活并调节移植物抗宿主病。
Immunohorizons. 2023 Jun 1;7(6):442-455. doi: 10.4049/immunohorizons.2300021.
7
Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease.利用和优化间充质干/基质细胞以改善移植物抗宿主病
World J Stem Cells. 2023 Apr 26;15(4):221-234. doi: 10.4252/wjsc.v15.i4.221.
8
Effects of immune system cells in GvHD and corresponding therapeutic strategies.免疫系统细胞在移植物抗宿主病中的作用及相应治疗策略。
Blood Res. 2023 Mar 31;58(1):2-12. doi: 10.5045/br.2023.2022192. Epub 2023 Feb 8.
9
Cell-free, Dendritic Cell-mimicking Extracellular Blebs for Molecularly Controlled Vaccination.用于分子控制疫苗接种的无细胞、模仿树突状细胞的细胞外小泡
Adv Ther (Weinh). 2023 Jan;6(1). doi: 10.1002/adtp.202200125. Epub 2022 Sep 13.
10
Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities.异基因干细胞移植治疗急性髓系白血病:障碍与机遇概述
World J Clin Cases. 2023 Jan 16;11(2):268-291. doi: 10.12998/wjcc.v11.i2.268.
Flt-3L 扩增受体 CD8α 树突状细胞可清除同种异体反应性供者 T 细胞,是移植后环磷酰胺预防移植物抗宿主病的替代方法。
Clin Cancer Res. 2018 Apr 1;24(7):1604-1616. doi: 10.1158/1078-0432.CCR-17-2148. Epub 2018 Jan 24.
4
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.急性移植物抗宿主病——生物学过程、预防与治疗
N Engl J Med. 2017 Nov 30;377(22):2167-2179. doi: 10.1056/NEJMra1609337.
5
Epigenetic Regulation of Dendritic Cell Development and Function.树突状细胞发育与功能的表观遗传调控
Cancer J. 2017 Sep/Oct;23(5):302-307. doi: 10.1097/PPO.0000000000000280.
6
Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors.髓系祖细胞中的转录异质性与谱系定向分化
Cell. 2016 Jan 14;164(1-2):325. doi: 10.1016/j.cell.2015.12.046.
7
Dendritic Cell Lineage Potential in Human Early Hematopoietic Progenitors.人类早期造血祖细胞中的树突状细胞谱系潜能
Cell Rep. 2017 Jul 18;20(3):529-537. doi: 10.1016/j.celrep.2017.06.075.
8
Lineage specification of human dendritic cells is marked by IRF8 expression in hematopoietic stem cells and multipotent progenitors.人类树突状细胞的谱系特化以造血干细胞和多能祖细胞中IRF8的表达为标志。
Nat Immunol. 2017 Aug;18(8):877-888. doi: 10.1038/ni.3789. Epub 2017 Jun 26.
9
Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.白血病造血干细胞移植后的移植物抗白血病效应
Front Immunol. 2017 Jun 7;8:496. doi: 10.3389/fimmu.2017.00496. eCollection 2017.
10
Genomic Characterization of Murine Monocytes Reveals C/EBPβ Transcription Factor Dependence of Ly6C Cells.鼠源单核细胞的基因组特征揭示了 C/EBPβ 转录因子对 Ly6C 细胞的依赖性。
Immunity. 2017 May 16;46(5):849-862.e7. doi: 10.1016/j.immuni.2017.04.018.